UPDATE 1-U.S. FDA approves Bristol-Myers, J&J HIV pills
January 29, 2015 at 18:35 PM EST
Jan 29 (Reuters) - The U.S. Food and Drug Administration on Thursday approved two fixed-dose HIV pills that combine protease inhibitors - one made by Bristol-Myers Squibb Co and the other by Johnson & Johnson - both with a boosting agent produced by Gilead Sciences Inc.
